From policy to prediction: Forecasting COVID-19 dynamics under imperfect vaccination
Xiunan Wang, Hao Wang, Pouria Ramazi, Kyeongah Nah, Mark Lewis

TL;DR
This study extends a COVID-19 forecasting model to include vaccination effects and policy impacts, demonstrating improved prediction accuracy and identifying key policy influences on disease spread.
Contribution
The paper introduces a modified ODE-based forecasting model that incorporates vaccination status and breakthrough cases, enhancing prediction accuracy during the post-vaccination period.
Findings
Inclusion of policy data improves forecast accuracy from 34% to 21%.
Restrictions on gatherings remain the most influential predictor.
The model effectively predicts COVID-19 cases up to 35 days ahead.
Abstract
Understanding the joint impact of vaccination and non-pharmaceutical interventions on COVID-19 development is important for making public health decisions that control the pandemic. Recently, we created a method in forecasting the daily number of confirmed cases of infectious diseases by combining a mechanistic ordinary differential equation (ODE) model for infectious classes and a generalized boosting machine learning model (GBM) for predicting how public health policies and mobility data affect the transmission rate in the ODE model [WWR+]. In this paper, we extend the method to the post-vaccination period, accordingly obtain a retrospective forecast of COVID-19 daily confirmed cases in the US, and identify the relative influence of the policies used as the predictor variables. In particular, our ODE model contains both partially and fully vaccinated compartments and accounts for the…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 epidemiological studies · COVID-19 Pandemic Impacts · SARS-CoV-2 and COVID-19 Research
